Observation Letter with "no adverse observation" received from BSE Limited in relation to the Scheme of…
As filed · Dabur India Limited has informed the Exchange about Observation Letter with "no adverse observation" received from BSE Limited in relation to the Scheme of Amalgamation of Sesa Care Private Limited wi
What happened
FactDabur India Limited has informed the Exchange about Observation Letter with "no adverse observation" received from BSE Limited in relation to the Scheme of Amalgamation of Sesa Care Private Limited with and into Dabur India Limited. Phiroze Jeejeebhoy Towers,. This is in furtherance to our intimation dated May 26, 2025 w. r.t. the Scheme of Amalgamation.
Why it matters
CapitSignal interpretationA merger fixes a share-exchange ratio, which permanently sets how much of the combined company existing holders own.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
Revised5% Volume Growth in India Business
7.2% CC Growth in International Business
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Swap ratio and its valuation basis
- Regulatory and NCLT approvals required
- Appointed date
- Going forward, we remain optimistic about a sequential recovery in consumption trends in 2025-26, supported by (management committed by FY26)
- As we look ahead to the next phase of our growth journey, we are entering a transformative phase guided by a r (management committed by FY28)
Evidence
- Dabur India Limited has informed the Exchange about Observation Letter with "no adverse observation" received from BSE Limited in relation to the Scheme of Amalgamation of Sesa Care Private Limited with and into Dabur India Limited(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- MERGER base 74; +4 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%